Market Research Logo

Vexim SA (ALVXM) - Product Pipeline Analysis, 2017 Update

Summary

Vexim SA (Vexim) is a healthcare product manufacturer that offers solutions for patients suffering from vertebral compression fractures. The company offers solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controlled anatomical restoration include biomaterials, cement mixing systems, 3D mapping software, and others. Vexim's advanced vertebroplasty therapy solutions offer a high-pressure injector for use with mixer that is specifically adapted to high viscosity cement. The company uses 3D reconstruction technique to evaluate the anatomical restoration in a clear and accurate way. Vexim is headquartered in Toulouse, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.Scope

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Vexim SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Vexim SA Company Overview
Vexim SA Company Snapshot
Vexim SA Pipeline Products and Ongoing Clinical Trials Overview
Vexim SA – Pipeline Analysis Overview
Vexim SA - Key Facts
Vexim SA - Major Products and Services
Vexim SA Pipeline Products by Development Stage
Vexim SA Ongoing Clinical Trials by Trial Status
Vexim SA Pipeline Products Overview
Implant Imagery Software
Implant Imagery Software Product Overview
SpineJack Implant
SpineJack Implant Product Overview
SpineJack Implant Clinical Trial
SpineJack Implant - 4.2 mm Diameter Model
SpineJack Implant - 4.2 mm Diameter Model Product Overview
SpineJack Implant - 6.5 mm Diameter Model
SpineJack Implant - 6.5 mm Diameter Model Product Overview
Vexim SA - Key Competitors
Vexim SA - Key Employees
Vexim SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Vexim SA, Recent Developments
Jul 11, 2017: VEXIM: Continued Growth and Adoption of the SpineJack in Q2 2017
May 29, 2017: VEXIM: ANVISA Approves SpineJack Implants in Brazil
Apr 19, 2017: VEXIM: Continued sales growth in Q1 2017
Apr 18, 2017: VEXIM: New Product Launch in Germany: MASTERFLOW PLUS, a New Product Targeted at Low Energy Osteoporotic Fractures
Oct 13, 2016: VEXIM: +37% sales increase to €13.3 million as of September 30, 2016 (9 months)
Mar 10, 2015: VEXIM Obtains CE Approval to Market Masterflow Injection System in Europe
Feb 19, 2015: VEXIM Announces Successful GMP Inspection by Brazil's National Health Surveillance Agency
Jan 26, 2015: VEXIM 2014 sales increase sharply by 69% to €10.3 million
Dec 10, 2014: Vexim Obtains FDA Approval To Market Masterflow Injection System In the United States
Nov 12, 2014: VEXIM Appoints National Sales Director for U.S. Market
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Vexim SA Pipeline Products and Ongoing Clinical Trials Overview
Vexim SA Pipeline Products by Equipment Type
Vexim SA Pipeline Products by Indication
Vexim SA Ongoing Clinical Trials by Trial Status
Vexim SA, Key Facts
Vexim SA, Major Products and Services
Vexim SA Number of Pipeline Products by Development Stage
Vexim SA Pipeline Products Summary by Development Stage
Vexim SA Ongoing Clinical Trials by Trial Status
Vexim SA Ongoing Clinical Trials Summary
Implant Imagery Software - Product Status
Implant Imagery Software - Product Description
SpineJack Implant - Product Status
SpineJack Implant - Product Description
SpineJack Implant - A Prospective, Multicenter, Randomized, Comparative Clinical Study to Compare the Safety and Effectiveness of Two Vertebral Compression Fracture (VCF) Reduction Techniques: The SpineJack and the KyphX Xpander Inflatable Bone Tamp
SpineJack Implant - Prospective Multicenter Randomized Study Comparing Two Standard Treatments: SpineJack System and Conservative Orthopedic Management in Acute Traumatic Vertebral Fractures Types A1 and A3.1 According to the Magerl Classification
SpineJack Implant - 4.2 mm Diameter Model - Product Status
SpineJack Implant - 4.2 mm Diameter Model - Product Description
SpineJack Implant - 6.5 mm Diameter Model - Product Status
SpineJack Implant - 6.5 mm Diameter Model - Product Description
Vexim SA, Key Employees
Vexim SA, Subsidiaries
Glossary
List of Figures
Vexim SA Pipeline Products by Equipment Type
Vexim SA Pipeline Products by Development Stage
Vexim SA Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report